Skip to main content
Premium Trial:

Request an Annual Quote

Genaissance Partner Licenses HAP Service to Japanese Med School

NEW YORK, Dec. 11 (GenomeWeb News) - Genaissance Pharmaceuticals will provide its haplotyping services to the Tokyo Women's Medical University for use in drug-response studies, the company said today.

 

The deal represents the first in a marketing partnership signed between Genaissance and Tokyo-based Intec Web and Genome Informatics Corporation in February 2002.

"We believe numerous Japanese government agencies and pharmaceutical companies plan to conduct genetic variation research over the next few years. We plan to capitalize on those opportunities," said Munehiro Sueoka, president of Intec, said in a statement.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.